A Study on Antiviral Treatment of Chronic Hepatitis B in Children

NARecruitingINTERVENTIONAL
Enrollment

1,900

Participants

Timeline

Start Date

May 6, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Chronic HBV Infection
Interventions
DRUG

Peginterferon alfa-2b combined and ETV

"Child patients are assigned to one of the 3 treatment regimens according to their illness state and treatment desire of their parents/guardians, and the number of patients in each group is expected to limited to 300.~1. NA monotherapy group : received entecavir (ETV) for 96 weeks.~2. Combination therapy group: received peginterferon alfa-2b combined with ETV for 96 weeks.~3. Pulse therapy group :received peginterferon alfa-2b pulse treatment combined with ETV for 144 weeks."

Trial Locations (1)

Unknown

RECRUITING

Shenzhen Third People Hospital, Shenzhen

All Listed Sponsors
lead

Fang Wang

OTHER